当前位置:首页 - 行情中心 - 昆药集团(600422) - 财务分析

昆药集团

(600422)

  

流通市值:103.10亿  总市值:103.10亿
流通股本:7.57亿   总股本:7.57亿

昆药集团(600422)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.23亿元,每股收益0.36元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益685571.88万元,未分配利润365706.47万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1200613.20万元,负债515041.32万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入4,751,206,077.583,351,347,279.451,608,452,032.428,401,447,233.37
营业总成本4,530,354,855.673,100,213,351.061,490,477,668.687,550,203,664.56
其他经营收益
营业利润379,298,300.11299,803,982.41148,463,945.82927,546,633.87
利润总额378,421,050.69298,940,268.97149,103,911.43934,570,238.35
净利润323,404,751.99249,920,820.76113,552,441.59751,220,665.56
每股收益
其他综合收益29,191.861,987,515.851,281,044.33-3,926,635.37
综合收益总额323,433,943.85251,908,336.61114,833,485.92747,294,030.19
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计7,961,178,600.978,635,256,590.098,680,727,395.488,555,000,337.24
非流动资产:
非流动资产合计4,044,953,367.664,022,532,237.034,023,796,766.214,056,366,796.33
资产总计12,006,131,968.6312,657,788,827.1212,704,524,161.6912,611,367,133.57
流动负债:
流动负债合计4,123,871,040.54,861,855,581.84,751,158,437.545,490,858,868.24
非流动负债:
非流动负债合计1,026,542,116.531,024,850,060.871,092,264,663.29374,240,690.39
负债合计5,150,413,157.035,886,705,642.675,843,423,100.835,865,099,558.63
所有者权益(或股东权益):
归属于母公司股东权益合计5,308,840,393.435,226,959,645.615,345,426,198.415,253,648,545.41
股东权益合计6,855,718,811.66,771,083,184.456,861,101,060.866,746,267,574.94
负债和股东权益合计12,006,131,968.6312,657,788,827.1212,704,524,161.6912,611,367,133.57
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计5,656,393,363.533,986,161,434.831,707,090,079.828,660,369,482.98
经营活动现金流出小计5,480,229,696.293,767,330,478.481,846,536,508.557,852,303,842.28
经营活动产生的现金流量净额176,163,667.24218,830,956.35-139,446,428.73808,065,640.7
投资活动产生的现金流量:
投资活动现金流入小计2,643,845,819.31,294,842,286.96626,227,207.713,155,459,063.77
投资活动现金流出小计4,118,725,860.542,657,025,967.731,669,948,028.733,069,431,061.47
投资活动产生的现金流量净额-1,474,880,041.24-1,362,183,680.77-1,043,720,821.0286,028,002.3
筹资活动产生的现金流量:
筹资活动现金流入小计1,392,199,133.631,253,539,493.46953,621,441.382,876,676,610.63
筹资活动现金流出小计1,506,012,944.111,099,931,735.21826,712,667.753,004,666,678.18
筹资活动产生的现金流量净额-113,813,810.48153,607,758.25126,908,773.63-127,990,067.55
汇率变动对现金及现金等价物的影响711,822.521,028,421.1235,093.62987,451.2
现金及现金等价物净增加额-1,411,818,361.96-988,716,545.05-1,056,223,382.5767,091,026.65
期末现金及现金等价物余额722,106,049.811,145,207,866.721,077,701,029.272,133,924,411.77
补充资料:
现金及现金等价物的净增加额--988,716,545.05-767,091,026.65
最新报告期:2025-09-19
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
兴业证券孙媛媛,董晓洁0.800.941.122025-09-19
中信建投袁全,刘若飞,贺菊颖0.800.891.022025-09-05
华泰证券代雯,唐庆雷,张云逸0.820.941.082025-08-19
开源证券余汝意,巢舒然0.831.001.212025-08-18
东吴证券朱国广0.810.981.182025-08-18
TOP↑